News

Below you will find links to various news. For NASDAQ-regulated press releases, please go here.

2020-10-12: https://news.cision.com/se/expres2ion-biotechnologies/r/biostock-expres2ion-skalar-upp-via-emission,c3212598

2020-10-06: https://news.cision.com/se/expres2ion-biotechnologies/r/biostock-expres2ion-storsatsar-pa-egna-vaccin,c3210908

2020-09-10: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-technology-platform-and-pipeline-at-several-key-events-in-september-and-,c3192286

2020-09-03: https://news.cision.com/expres2ion-biotechnologies/r/analysguiden-raises-its-target-price-for-expres2ion-to-24-sek-per-share,c3188075

2020-08-18: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-appoints-new-cfo,c3170265

2020-08-03: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-exercise-of-2017-warrant-program,c3163270

2020-07-17: https://us14.campaign-archive.com/?u=7a62af7c8c9f244ef950ab854&id=988aa59bd3

2020-07-17: https://news.cision.com/expres2ion-biotechnologies/r/strong-proof-of-concept-for-cross-strain-protective-flu-cvlp-vaccine-further-strengthens-confidence-,c3155745

2020-07-14: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-platform-to-be-used-in-a-novel-zika-vaccine-candidate,c3152394

2020-05-04: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-supporting-an-advantageous-covid-19-diagnostic-antibody-development-project,c3102671

2020-04-15: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-cso-dr--wian-de-jongh-co-signs-who-sanctioned-statement-from-83-covid-19-vaccine-resear,c3088606

2020-03-20: https://us14.campaign-archive.com/?u=7a62af7c8c9f244ef950ab854&id=b3518c858c

2020-03-16: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-expres2-platform-and-pipeline-at-several-key-events-in-march-and-april-2,c3050755

2020-03-05: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-will-present-its-expres2-platform-and-pipeline-at-several-key-events-in-march-and-april-2,c3050755

2020-01-23: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-s-ceo-in-interview-on-2019-and-the-company-s-new-way-forward-with-a-stronger-pipeline-foc,c3015046

2020-01-21: https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-is-streamlining-its-market-communication-with-english-as-primary-language,c3012218